Dr. Lasezkay has served as President and Chief Executive Officer of Clearside since March 2020, as Interim CEO from April 2019-March 2020, and has been a member of the board of directors since August 2018. Dr. Lasezkay has an accomplished history of success in the life sciences industry. For the past 15 years, he has served as an independent director on the boards of a number of domestic and foreign emerging biopharmaceutical companies, both public and private. Dr. Lasezkay currently serves on the board of directors of TheraVida, Inc., a clinical stage drug development company. Previously, Dr. Lasezkay served as Executive Vice President, General Counsel at Acucela Inc., a development stage company that specializes in identifying and developing novel ophthalmic therapeutics. For the 12 years prior to joining Acucela, he was President of Horizon Pharma Group, a private life sciences consultancy practice. Prior to his private consultancy practice, Dr. Lasezkay was Corporate Vice President for Corporate Development at Allergan, Inc., the global pharmaceutical and medical aesthetics company. His 13 years of progressive experience at Allergan includes a number of executive leadership positions, including being a member of the company’s Executive Committee, Assistant General Counsel for Commercial Affairs, and General Counsel for the Asia-Pacific Region. In these positions, he played a critical role in developing corporate strategy and was responsible for a wide variety of licensing, R&D collaboration and acquisition transactions involving new technologies, products and companies. Earning B.S. Pharmacy and Doctor of Pharmacy degrees from the State University of New York at Buffalo, and a J.D. degree from the Southern California Gould School of Law, Dr. Lasezkay also has a multi-disciplinary background in private firm and in-house legal practice, hospital pharmacy practice, clinical pharmacokinetics consultation and clinical drug research.
What is George M. Lasezkay's net worth?
The estimated net worth of George M. Lasezkay is at least $503,903.16 as of January 19th, 2024. Dr. Lasezkay owns 466,577 shares of Clearside Biomedical stock worth more than $503,903 as of November 22nd. This net worth approximation does not reflect any other investments that Dr. Lasezkay may own. Additionally, Dr. Lasezkay receives a salary of $836,150.00 as CEO at Clearside Biomedical. Learn More about George M. Lasezkay's net worth.
How old is George M. Lasezkay?
What is George M. Lasezkay's salary?
How do I contact George M. Lasezkay?
Has George M. Lasezkay been buying or selling shares of Clearside Biomedical?
George M. Lasezkay has not been actively trading shares of Clearside Biomedical over the course of the past ninety days. Most recently, George M. Lasezkay sold 18,000 shares of the business's stock in a transaction on Friday, January 19th. The shares were sold at an average price of $1.27, for a transaction totalling $22,860.00. Following the completion of the sale, the chief executive officer now directly owns 466,577 shares of the company's stock, valued at $592,552.79. Learn More on George M. Lasezkay's trading history.
Who are Clearside Biomedical's active insiders?
Are insiders buying or selling shares of Clearside Biomedical?
In the last year, Clearside Biomedical insiders bought shares 6 times. They purchased a total of 548,967 shares worth more than $728,031.93. In the last year, insiders at the sold shares 2 times. They sold a total of 30,900 shares worth more than $39,372.00. The most recent insider tranaction occured on November, 1st when insider Ngai Hang Victor Chong bought 36,500 shares worth more than $36,500.00. Insiders at Clearside Biomedical own 9.2% of the company.
Learn More about insider trades at Clearside Biomedical. Information on this page was last updated on 11/1/2024.
